Rafferty Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

Rafferty Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-30,358	Closed	-$124K	–	1266
2022 Q1	$124K	Sell	30,358 -11,064	-27%	-$40.1K	﹤0.01%	1162
2021 Q4	$148K	Sell	41,422 -445	-1%	-$1.56K	﹤0.01%	1242
2021 Q3	$152K	Buy	+41,867	New	+$169K	﹤0.01%	1202

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Rafferty Asset Management's ATRS Position: Q2 2022 in Review

Rafferty Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 30,358 shares — an estimated $124K sold.

Rafferty Asset Management first reported a position in ATRS in Q3 2021 and held it in 3 quarters. The position peaked at $152K in Q3 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Rafferty Asset Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Rafferty Asset Management sold 30,358 Antares Pharma, Inc. shares in Q2 2022, an estimated $124K.
Rafferty Asset Management first reported a position in Antares Pharma, Inc. in Q3 2021 and held it in 3 quarters.
Rafferty Asset Management's Antares Pharma, Inc. position peaked at $152K in Q3 2021.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Rafferty Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.